Rifampicin is a principal drug used to combat infections by mycobacteria and related organisms. Most strains of Mycobacterium are able to inactivate this antibiotic by ribosylation via an ADP-ribosylated intermediate. We found that this inactivation was inhibited by light at levels similar to those prevailing in laboratory environments. Rifampicin resistance arising from the cloned ADP-ribosyl transferase was also greatly diminished at these light levels. The cloned Rhodococcus equi monooxygenase which inactivates this antibiotic by a different mechanism was, in contrast, not inhibited by light. ß
Introduction
Sunlight has long been considered bene¢cial for individuals su¡ering from mycobacterial infections such as tuberculosis but studies in this direction have usually focussed on the e¡ects upon the patient's metabolism, for example elevating serum 25-hydroxy vitamin D [1] . More recently low-intensity laser radiation has been used together with drugs and shown to enhance the e¤cacy of such chemotherapeutic treatments [2] . We were interested to investigate if such bene¢ts might in part be due to light disabling the bacterial response to antibiotic challenge.
Rifampicin is a principal chemotherapeutic agent used to combat infections by Mycobacterium and related genera [3, 4] . Increasingly, clinical isolates show resistance to this and other antibiotics [5, 6] . Many clinical isolates are rifampicin resistant but do not have mutations in the known target of this antibiotic, RNA polymerase, suggesting another cellular component is altered [7, 8] . We have found that drug inactivation is part of response to rifampicin in these bacteria. Four mechanisms have been identi¢ed: decomposition [9] , phosphorylation [9] , glucosylation [10] , or ribosylation [11] . The last of these has been detected only in Mycobacterium and its close relatives [12] .
Gene disruption experiments have shown that presence of a functional ribosylation gene product reduces rifampicin susceptibility 12^15 fold in Mycobacterium smegmatis [13] and very recently we have found that the gene product initially ADP-ribosylates rifampicin, the ¢rst known instance of such an antibiotic inactivation mechanism [14] . Many bacterial mono (ADP-ribosyl) transferases are toxins, such as those of diphtheria, cholera, Bordetella pertussis or Clostridium botulinum C3 [15] . ADP-ribosylation of the nitrogen ¢xing enzyme dinitrogenase reductase in the photosynthetic bacterium Rhodospirillum rubrum mediates its reversible inactivation [16] . Bacteriophage T4 possesses two ADP-ribosylating activities targeting the host DNAdependent RNA polymerase and altering promoter specificity [17] . In all these cases the acceptors are proteins and the ADP-ribosyl moiety is joined to a nitrogen atom. However ADP-ribosylation of rifampicin is on an oxygen atom [14] . Endogenous mono ADP-ribosylation has been demonstrated in several bacteria including M. smegmatis [18] , but little is known about the physiological role of this modi¢cation process.
M. smegmatis possesses at least two rifampicin inactivation systems [13] and at least one additional rifampicin resistance determinant which is not RNA polymerase [19] . Therefore to separate the e¡ects on individual cellular components interacting with this antibiotic we studied the in£uence of light on cloned rifampicin inactivation genes in organisms unable themselves to inactivate the drug, Rhodococcus rhodochrous strain CW25 (closely related to Mycobacterium) and Escherichia coli. We compared the ADP-ribosyl transferase (adr) gene with the rifampicin inactivation gene (iri) cloned from the opportunistic pathogen Rhodococcus equi, which on the basis of sequence is a monooxygenase [20] .
Materials and methods

Bacterial strains and plasmids
These are listed in Table 1 . E. coli and R. rhodochrous were grown in Luria Bertani medium at 37³C and 28³C, respectively. Plasmids were selected for and maintained in E. coli by the addition of ampicillin, 100 Wg ml 31 ; in nocardioform strains they were selected using 40 Wg ml 31 chloramphenicol and maintained using 20 Wg ml 31 of this antibiotic. Shuttle vector pDA71 [21] is able to replicate in both E. coli and a number of nocardioform bacteria; it has a positive selection function due to the EcoR endonuclease with expression turned o¡ by the V repressor so it is maintained in a V lysogen of E. coli. Plasmid transformations were performed as previously described [13, 22, 23] .
DNA manipulations
Restriction endonucleases and other enzymes used in DNA manipulations were employed according to the manufacturer's instructions. All restriction mapping was done using DNA from E. coli dam dcm strain GM2929 (Table  1) . Chromosomal and plasmid DNAs were puri¢ed by cesium chloride gradient centrifugation as described previously [23] . DNA fragments were puri¢ed after electrophoresis through low gelling temperature agarose (SeaPlaque).
Rifampicin inactivation and susceptibility testing
Rifampicin concentrations were measured by zones of inhibition on plates spread with a lawn Bacillus subtilis strain 1A3-1 [24] . Rifampicin minimum inhibitory concentration (MIC) was found by spotting about 10 4 cfu on plates with a range of antibiotic concentrations, using a replicator; the highest concentration at which there was con£uent growth was taken as the resistance level. Plates were incubated for 5^6 days in the case of nocardioform strains or 14 h for E. coli. Illumination was measured in lx (lumen per square meter) using a Type 3281 Luxmeter (Yokogawa Hokushin Electric Co.).
SDS-polyacrylamide gels
These were prepared according to the method of Hames and Rockwood [25] . Separating gel was 10% acrylamide and stacking gel 6% prepared from an acrylamide:bisacrylamide 30:0.8 stock. E. coli extracts were prepared from 1-ml aliquots of stationary phase culture. Electrophoresis of samples, together with Bio-Rad low molecular mass standards, was at a constant current of 25 mA for 3.5 h. Proteins were visualized by staining with amido black.
Results and discussion
3.1. Choice of strain for testing e¡ects of illumination on rifampicin inactivation ability due to cloned genes
Response to rifampicin challenge of M. smegmatis and most related organisms involves two or more other determinants apart from RNA polymerase [13] so to investigate the e¡ects of light upon a cloned individual component of this response strain CW25, a closely related bacterium, was used. CW25 cannot inactivate rifampicin and so is highly susceptible to this antibiotic: it has an MIC of 30 ng ml 31 in contrast to M. smegmatis strain DSM43756 which has an MIC of 20 Wg ml 31 . The M. smegmatis rifampicin ADP-ribosylation gene (adr), the R. equi rifampicin monooxygenase gene (iri), each carried by E. coliRhodococcus shuttle plasmid pDA71, were transformed into CW25 as was vector pDA71 itself.
Cultures of these transformants were challenged with 20 Wg ml 31 rifampicin and the residual antibiotic assayed, as previously described [24] . When cultures carrying the ADP-ribosyl transferase clone were illuminated with visible light, the antibiotic inactivation process was completely inhibited at 600 lx, illumination comparable to that measured in laboratory environments; at 200 lx the rate was already substantially reduced (Fig. 1) . In contrast inactivation of the drug by the iri-encoded monooxygenase was not inhibited at all even at 1000 lx. As controls, the endogenous aminoglycoside or macrolide inactivation activities of strain CW25 were tested but neither was signi¢cantly inhibited by light. The growth rate of strain CW25 was not measurably impaired by light at 1000 lx.
E¡ect of light upon antibiotic susceptibility in E. coli transformed with rifampicin inactivation genes or carrying an rpoB mutation
Both rifampicin inactivation genes confer a phenotype of increased resistance to the antibiotic upon strain CW25, respectively, 15 and 150 fold for adr and iri [21] . Light apparently abolished this e¡ect in the case of the former clone but not the latter; however, the prolonged exposure to light necessary for full growth of nocardioform transformants ( s 5 days) resulted in partial bleaching of the antibiotic. To minimize the e¡ects of bleaching further experiments were performed in the much faster growing E. coli. Like CW25, this organism is unable to inactivate rifampicin. Both strain MM 294-4 and a derivative of MM294-4 with an rpoB chromosomal mutation conferring rifampicin resistance showed a increase in MIC with increasing illumination (Fig. 2a,b) . The adr gene carried on plasmid pS3 is apparently expressed from its own promoter in E. coli [13] conferring an approximately threefold increase in antibiotic MIC but this increase was abolished by s 600 lx illumination (Fig. 2d) . Expression of adr from the lac promoter conferred much higher drug resistance [13] , to 100 Wg ml 31 , but illumination reduced this and at 800 lx abolished it completely (Fig. 2e) : the MIC of 5 Wg ml 31 was similar to that of E. coli not carrying any resistance determinants (Fig. 1a) . The results with the ADP-ribosyl transferase expressed from the lac promoter suggested that light did not exert its e¡ect at the promoter level but on later stages of gene expression.
Contrasting e¡ect of light upon antibiotic inactivation
and resistance due to the rifampicin monooxygenase gene
This conclusion was supported by the contrasting e¡ects of light on rifampicin inactivation by the clones in strain CW25 (Fig. 1) , though the iri and adr ORFs show no signi¢cant similarity their putative regulatory upstream DNA sequences are strikingly alike, suggesting common features in regulation [13, 21] . Plasmid pSAN1 (pDA71 carrying the R. equi iri gene) was transformed into strain MM294-4, the construct expressing the monooxygenase enzyme from the VP R promoter since previous work had demonstrated it is not signi¢cantly expressed from its own promoter in E. coli and that high level expression from the lac promoter is toxic to this organism [20] . Increasing illumination did not lower rifampicin MIC but instead moderately increased it (Fig. 2c) . In addition, other plasmid-borne determinants were tested in E. coli: L-lactam, chloramphenicol, and tetracycline resistance genes (the ¢rst two being antibiotic inactivation mechanisms). None of these showed reduced MICs in the presence of light.
E¡ect of illumination upon presence of cloned ADP-ribosyl transferase gene product in cell extracts
SDS-polyacrylamide gels of extracts from an E. coli transformant carrying pGEM3Z-Bst49 demonstrated that growth in the presence of light (1000 lx) resulted in the almost complete disappearance of the band corresponding to the adr gene product (Fig. 3) . This indicated that the protein (or its mRNA) was photolabile rather than that the enzyme was present in normal amounts but inactive in the presence of light. Interestingly, R. rubrum and some other photosynthetic bacteria have a nitrogenase which is regulated in part by ADP-ribosylation and this ADP-ribosyl transferase is inhibited by light [16] . The relevant genes of Rhodospirillum and M. smegmatis show no sequence similarity however and whereas in the former organism the process is reversible it is irreversible in the latter.
Therefore the signi¢cance of this parallel remains to be determined.
